Literature DB >> 28337269

The role of PRRX1 in the apoptosis of A549 cells induced by cisplatin.

Hongbin Zhu1, Gengyun Sun2, Jiahui Dong2, Liming Fei2.   

Abstract

Paired related homeobox1 (PRRX1) was a newly identified Epithelial mesenchymal transition (EMT) inducer. It was found that the decreased expression of PRRX1 in breast cancer and liver cancer could enable tumor cells to obtain tumor stem cell characteristics in vitro studies. However, the role of PRRX1 in lung cancer was still unknown. The down-regulated PRRX1 gene in A549 cells was established by slow virus infection in this study. The apoptosis of A549 cells was observed after the treatment of different concentrations of cisplatin and the role of PRRX1 in the apoptosis of A549 cells was explored. MTT results showed that down-regulated PRRX1 gene could resist the inhibitory effect of cisplatin on cell proliferation. The results of flow cytometry assay showed that down-regulated PRRX1 gene could reduce the apoptosis and promote A549 cells to enter G2 phase. Mitochondrial membrane potential detection showed that PRRX1 gene could inhibit the decrease of mitochondrial membrane potential. Western blotting results showed that down-regulated PRRX1 gene could reduce the expression levels of Caspase3, caspase9, Apaf-1 and cytochrome C. In a word, down-regulation of PRRX1 could cause lung cancer cells to produce anti apoptotic ability and resistance to cisplatin, which maybe through caspase3 pathway.

Entities:  

Keywords:  A549 cells; PRRX1; apoptosis; cisplatin

Year:  2017        PMID: 28337269      PMCID: PMC5340676     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  20 in total

Review 1.  The ins and outs of the epithelial to mesenchymal transition in health and disease.

Authors:  M Angela Nieto
Journal:  Annu Rev Cell Dev Biol       Date:  2011-07-08       Impact factor: 13.827

2.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

3.  CD13 is a therapeutic target in human liver cancer stem cells.

Authors:  Naotsugu Haraguchi; Hideshi Ishii; Koshi Mimori; Fumiaki Tanaka; Masahisa Ohkuma; Ho Min Kim; Hirofumi Akita; Daisuke Takiuchi; Hisanori Hatano; Hiroaki Nagano; Graham F Barnard; Yuichiro Doki; Masaki Mori
Journal:  J Clin Invest       Date:  2010-08-09       Impact factor: 14.808

Review 4.  Do newer chemotherapeutic agents improve survival in non-small cell lung cancer?

Authors:  J R Rigas
Journal:  Semin Oncol       Date:  1998-06       Impact factor: 4.929

5.  The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis.

Authors:  Maximilian Reichert; Shigetsugu Takano; Johannes von Burstin; Sang-Bae Kim; Ju-Seog Lee; Kaori Ihida-Stansbury; Christopher Hahn; Steffen Heeg; Günter Schneider; Andrew D Rhim; Ben Z Stanger; Anil K Rustgi
Journal:  Genes Dev       Date:  2013-01-25       Impact factor: 11.361

6.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

7.  Human and Drosophila homeodomain proteins that enhance the DNA-binding activity of serum response factor.

Authors:  D A Grueneberg; S Natesan; C Alexandre; M Z Gilman
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

8.  EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.

Authors:  Taro Yamashita; Junfang Ji; Anuradha Budhu; Marshonna Forgues; Wen Yang; Hong-Yang Wang; Huliang Jia; Qinghai Ye; Lun-Xiu Qin; Elaine Wauthier; Lola M Reid; Hiroshi Minato; Masao Honda; Shuichi Kaneko; Zhao-You Tang; Xin Wei Wang
Journal:  Gastroenterology       Date:  2008-12-06       Impact factor: 22.682

9.  Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib.

Authors:  Takeshi Yamada; Masato Abei; Inaho Danjoh; Ryoko Shirota; Taro Yamashita; Ichinosuke Hyodo; Yukio Nakamura
Journal:  BMC Cancer       Date:  2015-04-11       Impact factor: 4.430

10.  CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells.

Authors:  Yi Chen; Dongke Yu; Hao Zhang; Hongwei He; Caixia Zhang; Wuli Zhao; Rong-Guang Shao
Journal:  Int J Biol Sci       Date:  2012-08-01       Impact factor: 6.580

View more
  5 in total

1.  Procaspase-3 Overexpression in Cancer: A Paradoxical Observation with Therapeutic Potential.

Authors:  Matthew W Boudreau; Jessie Peh; Paul J Hergenrother
Journal:  ACS Chem Biol       Date:  2019-07-16       Impact factor: 5.100

2.  Population-Specific Genetic and Expression Differentiation in Europeans.

Authors:  Xueyuan Jiang; Raquel Assis
Journal:  Genome Biol Evol       Date:  2020-04-01       Impact factor: 3.416

3.  Paired‑related homeobox 1 overexpression promotes multidrug resistance via PTEN/PI3K/AKT signaling in MCF‑7 breast cancer cells.

Authors:  Haoyue Luo; Shaobo Cong; Jiaojiao Dong; Litao Jin; Dandan Jiang; Xingang Wang; Qingfeng Chen; Funian Li
Journal:  Mol Med Rep       Date:  2020-08-04       Impact factor: 2.952

4.  The rs7911488-T allele promotes the growth and metastasis of colorectal cancer through modulating miR-1307/PRRX1.

Authors:  Man Yang; Xinchang Liu; Fanyi Meng; Yawen Zhang; Mengmeng Wang; Yinshuang Chen; Xuqin Guo; Weichang Chen; Weipeng Wang
Journal:  Cell Death Dis       Date:  2020-08-07       Impact factor: 8.469

Review 5.  The Regulatory Role of PRRX1 in Cancer Epithelial-Mesenchymal Transition.

Authors:  Wenjiao Du; Xinchang Liu; Man Yang; Weipeng Wang; Jing Sun
Journal:  Onco Targets Ther       Date:  2021-07-16       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.